Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...
bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release. The test ...
Polymerase chain reaction testing may be more clinically effective than chromogenic agar for MRSA screening, according to research published in BMC Infectious Diseases. For their study, researcher ...
September 13, 2009 (San Francisco, California) — Universal screening using rapid polymerase chain reaction (PCR) analysis for methicillin-resistant Staphylococcus aureas (MRSA) in hospitals appears to ...
Jan. 27, 2003 — Screening for methicillin-resistant Staphylococcus aureus (MRSA) infections is beneficial in patients admitted to the intensive care unit (ICU), according to the results of a ...
A survey released today by the Association for Professionals in Infection Control and Epidemiology and the American Society for Microbiology showed the turnaround time for laboratory test results may ...
There has been a sharp rise in cases of the superbug MRSA being contracted outside hospitals across the UK. Britons have been urged to avoid sharing items such as towels or razors, particularly in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback